Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-8 POS Registration of securities for employees (post-effective amendment)
- 5.1 Opinion of Cooley LLP
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.4 Arena Pharmaceuticals, Inc. Amended and Restated 2017 Long-term Incentive Plan
- 99.5 Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-term Incentive Plan
- 99.6 Form of Nonqualified Stock Option Grant Agreement for Employees and Consultants Under the Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-term Incentive Plan
- 99.7 Form of Restricted Stock Unit Grant Agreement Under the Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-term Incentive Plan
- 99.8 Form of Restricted Stock Unit Grant Agreement for Non-employee Directors Under the Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-term Incentive Plan
- 99.9 Form of Nonqualified Stock Option Grant Agreement for Non-employee Directors Under the Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-term Incentive Plan
Associated filings
- 11 Mar 22 S-8 POS Registration of securities for employees (post-effective amendment)
- 14 Jun 21 S-8 POS Registration of securities for employees (post-effective amendment)
-
19 Jun 20 S-8 POS Registration of securities for employees (post-effective amendment)
ARNA similar filings
- 14 Jun 21 Registration of securities for employees (post-effective amendment)
- 14 Jun 21 Registration of securities for employees (post-effective amendment)
- 14 Jun 21 Registration of securities for employees (post-effective amendment)
- 19 Jun 20 Registration of securities for employees (post-effective amendment)
- 19 Jun 20 Registration of securities for employees (post-effective amendment)
- 19 Jun 20 Registration of securities for employees (post-effective amendment)
- 19 Jun 20 Registration of securities for employees (post-effective amendment)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Arena Pharmaceuticals, Inc.:
We consent to the use of our reports with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein. Our report with respect to the consolidated financial statements refers to the adoption of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, and the adoption of Accounting Standards Codification Topic 842, Leases.
/s/ KPMG LLP
San Diego, California
June 19, 2020